Brokerages Set Addus HomeCare Co. (NASDAQ:ADUS) Price Target at $112.14

Addus HomeCare Co. (NASDAQ:ADUS) has been given an average rating of “Moderate Buy” by the eight analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and seven have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $112.14.

A number of equities analysts have issued reports on ADUS shares. Royal Bank of Canada restated an “outperform” rating and issued a $102.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 29th. Oppenheimer boosted their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. StockNews.com upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 6th. Bank of America boosted their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. Finally, TD Cowen boosted their price target on shares of Addus HomeCare from $105.00 to $119.00 and gave the company a “buy” rating in a research report on Thursday, May 9th.

Addus HomeCare Price Performance

ADUS stock opened at $117.70 on Friday. The firm’s 50-day moving average price is $105.98 and its two-hundred day moving average price is $98.31. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $119.98. The stock has a market capitalization of $1.93 billion, a price-to-earnings ratio of 29.21, a PEG ratio of 2.22 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The firm had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same quarter in the previous year, the company earned $0.84 earnings per share. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. As a group, equities analysts predict that Addus HomeCare will post 4.36 earnings per share for the current year.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds have recently bought and sold shares of ADUS. Boston Partners bought a new position in shares of Addus HomeCare in the first quarter worth approximately $12,215,000. Hancock Whitney Corp lifted its stake in shares of Addus HomeCare by 5.4% in the first quarter. Hancock Whitney Corp now owns 5,102 shares of the company’s stock worth $527,000 after buying an additional 263 shares in the last quarter. Janus Henderson Group PLC lifted its stake in shares of Addus HomeCare by 683.7% in the first quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock worth $5,703,000 after buying an additional 48,146 shares in the last quarter. Lazard Asset Management LLC lifted its stake in shares of Addus HomeCare by 11.9% in the first quarter. Lazard Asset Management LLC now owns 5,128 shares of the company’s stock worth $529,000 after buying an additional 547 shares in the last quarter. Finally, Quadrature Capital Ltd bought a new position in shares of Addus HomeCare in the first quarter worth approximately $1,557,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.